| Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors (NCT03693846) | Abramson Cancer Center at Penn Medicine | 2019-02-15 |
| Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver (NCT02110953) | Fox Chase Cancer Center | 2016-01-29 |
| Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer (NCT02235324) | University of Southern California | 2015-03-01 |
| CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery (NCT02232152) | Wake Forest University Health Sciences | 2015-01-06 |
| Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer (NCT02270606) | Virginia Commonwealth University | 2014-12-04 |
| Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation (NCT02132858) | Fox Chase Cancer Center | 2014-07-01 |
| Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy (NCT01934179) | Fox Chase Cancer Center | 2013-10-01 |
| Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer (NCT01871571) | University of Southern California | 2013-08-02 |
| Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer (NCT01923337) | University of California, Davis | 2013-08-01 |
| Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab (NCT01814501) | John Hays | 2013-02-01 |
| Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer (NCT01652196) | John Hays | 2012-11-14 |
| Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer (NCT01403103) | Case Comprehensive Cancer Center | 2012-04-01 |
| Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer (NCT01285102) | Fox Chase Cancer Center | 2010-10-01 |
| Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery (NCT01197664) | Wake Forest University Health Sciences | 2010-08-01 |
| Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery (NCT00835679) | National Cancer Institute (NCI) | 2009-12-01 |
| A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer (NCT00060411) | National Cancer Institute (NCI) | 2003-06-01 |
| Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer (NCT00052585) | National Cancer Institute (NCI) | 2002-10-01 |
| Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (NCT00005036) | National Cancer Institute (NCI) | 1999-11-01 |
| Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer (NCT00003799) | National Cancer Institute (NCI) | 1999-05-01 |
| Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer (NCT00002796) | National Cancer Institute (NCI) | 1997-05-01 |